Astellas Pharma
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Astellas Pharma often yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. The company occasionally embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues at times. This approach fails to safeguard free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportHas canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Astellas Pharma received a score of 70 on the 2025 Corporate Equality Index (CEI) from the Human Rights Campaign (HRC), a political stakeholder group. The company recruits employees based on sexual identity issues. The company discriminates against vendors that do not promote divisive sex and gender policies, indicating it prioritizes sexual issues over merit (1)(2). Astellas Pharma fired numerous employees for refusing to receive the COVID-19 vaccine after filing for religious exemptions (1).
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Astellas Pharma does not discriminate against charitable organizations based on views or beliefs (1).
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Astellas Pharma’s HRC 2025 CEI rating indicates the company provides gender transition guidelines for its employees (1)(2). The company provides manager training focused on diversity and unconscious and conscious biases (3). Astellas Pharma does not provide viewpoint protections for its employees (4).
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Astellas Pharma’s HRC 2025 CEI rating indicates the company covers transgender related costs for its employees and their children, including paid short-term leave, puberty blockers, cross-sex hormones, chest surgeries, genital surgeries, medical visits and lab monitoring, travel and lodging. By allowing a political stakeholder group to dictate operations, the company increases health care costs and risks dividing employees, alienating customers and harming shareholders (1)(2). Astellas Pharma also sponsored an LGBTQ mobile art exhibit and is a Copper sponsor of Out & Equal (3)(4).
Board Bias
Expand Summary
1792 Exchange has not yet compiled data about the board of directors or political contributions of leadership for this company.